The one-and-a-half syndrome in systemic lupus erythematosus.
We report a case of one-and-a-half syndrome occurring as the first manifestation of central nervous system (CNS) involvement in systemic lupus erythematosus (SLE). The lesion in the pons was documented with magnetic resonance imaging (MRI). The patient responded quite satisfactorily to high-dose i.v. methyl-prednisolone therapy.
Yiğit
A
A
Department of Neurology, Faculty of Medicine, University of Ankara, Turkey.
Bingöl
A
A
Mutluer
N
N
Taşçilar
N
N
D000368:Aged; D001927:Brain Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy; D008279:Magnetic Resonance Imaging; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D015835:Ocular Motility Disorders / Q000188:drug therapy / Q000209:etiology*; D009886:Ophthalmoplegia / Q000188:drug therapy / Q000209:etiology; D011149:Pons / Q000187:drug effects / Q000473:pathology*; D013577:Syndrome
D005938:Glucocorticoids; D008775:Methylprednisolone